Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection

被引:0
作者
de Bont, N
Netea, MG
Demacker, PNM
Verschueren, I
Kullberg, BJ
van Dijk, KW
van der Meer, JWM
Stalenhoef, AFH [1 ]
机构
[1] Univ Nijmegen Hosp, Dept Med, Div Gen Internal Med, NL-6500 HB Nijmegen, Netherlands
[2] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands
关键词
lipopolysaccharide; tumor necrosis factor; apolipoprotein E; hypercholesterolemia; neutralization;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipoproteins are able to neutralize bacterial lipopolysaccharide (LPS) and thereby inhibit the proinflammatory cytokine response. In a previous study, we demonstrated that hypercholesterolemic lour density lipoprotein receptor knock-out (LDLr-/-) mice are protected against lethal endotoxemia and gram-negative infection, In the present study we investigated the susceptibility of apolipoprotein E knock-out mice (apoE-/-) to LPS and to Klebsiella pneumoniae. These mice have increased plasma lipoprotein concentrations in the very low density lipoprotein (VLDL)-sized fraction. Despite 8-fold higher plasma cholesterol levels compared to controls, and in contrast to LDLr-/- mice, apoE-/- mice were significantly more susceptible to endotoxemia and to K. pneumoniae infection. Circulating TNF alpha concentrations after intravenously injected LPS were 4- to 5-fold higher in apoE-/- mice, whereas IL-1 alpha, IL-1 beta, and IL-6 did not differ. This TNF response was not due to an increased cytokine production capacity of cells from apoE-/- mice, as ex vivo cytokine production in response to LPS did not differ between apoE-/- and control mice. The LPS-neutralizing capacity of apoE-/- plasma was significantly less than that of controls. Most likely, the absence of apoE itself in the knock-out mice explains the failure to neutralize LPS, despite the very high cholesterol concentrations.
引用
收藏
页码:680 / 685
页数:6
相关论文
共 28 条
[1]   CYTOKINE RESPONSE BY MONOCYTES AND MACROPHAGES TO FREE AND LIPOPROTEIN-BOUND LIPOPOLYSACCHARIDE [J].
CAVAILLON, JM ;
FITTING, C ;
HAEFFNERCAVAILLON, N ;
KIRSCH, SJ ;
WARREN, HS .
INFECTION AND IMMUNITY, 1990, 58 (07) :2375-2382
[2]   INVITRO INACTIVATION OF BACTERIAL-ENDOTOXIN BY HUMAN LIPOPROTEINS AND APOLIPOPROTEINS [J].
EMANCIPATOR, K ;
CSAKO, G ;
ELIN, RJ .
INFECTION AND IMMUNITY, 1992, 60 (02) :596-601
[3]   INHIBITION OF ENDOTOXIN-INDUCED ACTIVATION OF HUMAN-MONOCYTES BY HUMAN LIPOPROTEINS [J].
FLEGEL, WA ;
WOLPL, A ;
MANNEL, DN ;
NORTHOFF, H .
INFECTION AND IMMUNITY, 1989, 57 (07) :2237-2245
[4]   PREVENTION OF ENDOTOXIN-INDUCED MONOKINE RELEASE BY HUMAN LOW- AND HIGH-DENSITY-LIPOPROTEINS AND BY APOLIPOPROTEIN-A-I [J].
FLEGEL, WA ;
BAUMSTARK, MW ;
WEINSTOCK, C ;
BERG, A ;
NORTHOFF, H .
INFECTION AND IMMUNITY, 1993, 61 (12) :5140-5146
[5]   CHYLOMICRONS ALTER THE FATE OF ENDOTOXIN, DECREASING TUMOR-NECROSIS-FACTOR RELEASE AND PREVENTING DEATH [J].
HARRIS, HW ;
GRUNFELD, C ;
FEINGOLD, KR ;
READ, TE ;
KANE, JP ;
JONES, AL ;
EICHBAUM, EB ;
BLAND, GF ;
RAPP, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) :1028-1034
[6]   HUMAN VERY LOW-DENSITY LIPOPROTEINS AND CHYLOMICRONS CAN PROTECT AGAINST ENDOTOXIN-INDUCED DEATH IN MICE [J].
HARRIS, HW ;
GRUNFELD, C ;
FEINGOLD, KR ;
RAPP, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (03) :696-702
[7]  
HUBSCH AP, 1993, CIRC SHOCK, V40, P14
[8]   HYPERCHOLESTEROLEMIA IN LOW-DENSITY-LIPOPROTEIN RECEPTOR KNOCKOUT MICE AND ITS REVERSAL BY ADENOVIRUS-MEDIATED GENE DELIVERY [J].
ISHIBASHI, S ;
BROWN, MS ;
GOLDSTEIN, JL ;
GERARD, RD ;
HAMMER, RE ;
HERZ, J .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (02) :883-893
[9]   IN-VIVO PROTECTION AGAINST ENDOTOXIN BY PLASMA HIGH-DENSITY-LIPOPROTEIN [J].
LEVINE, DM ;
PARKER, TS ;
DONNELLY, TM ;
WALSH, A ;
RUBIN, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :12040-12044
[10]  
LOURY OH, 1951, J BIOL CHEM, V193, P265